Bioconjugation specialist Expedeon acquired by SYGNIS AG

June 26th, 2017

Innova CEO and CSO Dr. Nick Gee becomes Chief Technical Officer of SYGNIS Madrid, Spain, Heidelberg, Germany, and Cambridge, UK, 26th June 2017: Expedeon (Innova), a specialist provider of bioconjugation products and services, has announced it has been fully acquired by Sygnis AG, for EUR 8 million in cash and 3.5 million in shares. Innova’s…

View

Enzyme labels for immunodetection

June 23rd, 2017

One of the most popular methods of immunodetection is to pair an enzyme-labeled antibody with an appropriate substrate. Enzymatic conversion of the substrate produces a colored, fluorescent or chemiluminescent readout, which can be used to determine the quantity of antigen present in the test sample. The most commonly used immunodetection enzymes are Horseradish Peroxidase (HRP),…

View

TTP plc and Expedeon extend partnership to develop rapid point-of-care diagnostics

June 13th, 2017

Innova to continue to provide custom bioconjugation services to support TTP’s Desktop Biology initiative Cambridge, UK, 13 June 2017: TTP plc, Europe’s leading technology and product development company, today announces its ongoing partnership with Expedeon (Innova), a specialist provider of bioconjugation products and services, to enable its rapid point-of-care diagnostics development program. TTP’s Desktop Biology…

View

AACC – FREE Exhibit Hall Guest Pass

June 13th, 2017

FREE Exhibit Hall Guest Pass 69th AACC Annual Scientific Meeting & Clinical Lab Expo We are attending the 69th AACC Annual Scientific Meeting & Clinical Lab Expo this July in San Diego. As you might be aware, AACC is an opportunity to connect with global leaders in clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, lab…

View

Your preferred local currency is now